about
Crystal Structure of the Fab Fragment of an Anti-ofloxacin Antibody and Exploration of Its Specific BindingWildlife contamination with fluoroquinolones from livestock: Widespread occurrence of enrofloxacin and marbofloxacin in vultures.In vitro Dynamic Pharmacokinetic/Pharmacodynamic (PK/PD) study and COPD of Marbofloxacin against Haemophilus parasuis.Pharmacokinetics/pharmacodynamics of marbofloxacin in a Pasteurella multocida serious murine lung infection model.In vivo antimicrobial activity of marbofloxacin against Pasteurella multocida in a tissue cage model in calves.Impact of Timing and Dosage of a Fluoroquinolone Treatment on the Microbiological, Pathological, and Clinical Outcomes of Calves Challenged with Mannheimia haemolytica.Pharmacokinetic/pharmacodynamic relationship of marbofloxacin against Aeromonas hydrophila in Chinese soft-shelled turtles (Trionyx sinensis).Effects of concurrent perioperative use of marbofloxacin and cimicoxib or carprofen in dogs.Marbofloxacin-encapsulated microparticles provide sustained drug release for treatment of veterinary diseases.Evaluating synergy between marbofloxacin and gentamicin in Pseudomonas aeruginosa strains isolated from dogs with otitis externa.Pharmacokinetics of enrofloxacin and marbofloxacin in Japanese quails and common pheasants.Use of micellar liquid chromatography to analyze oxolinic acid, flumequine, marbofloxacin and enrofloxacin in honey and validation according to the 2002/657/EC decision.Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of marbofloxacin after intravenous and intramuscular administration in beagle dogs.Determination of marbofloxacin in plasma and synovial fluid by ultrafiltration followed by HPLC-MS/MS
P921
Q27704235-DF299D71-18C3-444B-B31F-2C8EF0E7262EQ35820084-99958587-4C1F-4775-B700-0286976AFDEBQ35857801-C4503516-28EF-407E-96FF-9B78ED60B711Q35859460-B5EAFDE3-912B-411B-9997-6D4A577CBAD5Q35884208-EB97DBDB-A0DF-4DAC-9C7B-0FB39C4A8B8EQ36637193-AD140A49-9A98-4D21-B9C1-3D0AD22D04DEQ39451183-ABA9C65D-D4AF-4162-A219-101FBD849E27Q40826392-CD9484B4-6C7A-435E-8B20-869F5F873894Q40856601-E49A16FA-EE6A-41D0-9D48-56C6DD7FF48FQ41370147-3C33EB19-25EC-40C4-BBFC-F9D7803D5C97Q41557797-B15B12E5-72CB-481A-A65E-823DEEB61C04Q47882248-91E3FCB4-8217-45CC-9F0F-E8643C93A4B9Q53247094-F33BAD90-C98D-4279-B292-4E1315E1F1B5Q87256458-7D6703B1-A78B-4ECC-9095-1D540D5B384D
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
desmethylmarbofloxacin
@en
type
label
desmethylmarbofloxacin
@en
prefLabel
desmethylmarbofloxacin
@en
P662
P683
P2067
P233
CN1CCN(CC1)C2=C(C=C3C4=C2OCNN4C=C(C3=O)C(=O)O)F
P234
1S/C16H17FN4O4/c1-19-2-4-20(5- ...... h6-7,18H,2-5,8H2,1H3,(H,23,24)
P235
LPVVTHNMXSEIFM-UHFFFAOYSA-N
P274
C₁₆H₁₇FN₄O₄